DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists.

MLA

Naqvi, Ibtehaj, et al. “DAMPs/PAMPs Induce Monocytic TLR Activation and Tolerance in COVID-19 Patients; Nucleic Acid Binding Scavengers Can Counteract Such TLR Agonists.” Biomaterials, vol. 283, Apr. 2022, p. 121393. EBSCOhost, https://doi.org/10.1016/j.biomaterials.2022.121393.

APA

Naqvi, I., Giroux, N., Olson, L., Morrison, S. A., Llanga, T., Akinade, T. O., Zhu, Y., Zhong, Y., Bose, S., Arvai, S., Abramson, K., Chen, L., Que, L., Kraft, B., Shen, X., Lee, J., Leong, K. W., Nair, S. K., & Sullenger, B. (2022). DAMPs/PAMPs induce monocytic TLR activation and tolerance in COVID-19 patients; nucleic acid binding scavengers can counteract such TLR agonists. Biomaterials, 283, 121393. https://doi.org/10.1016/j.biomaterials.2022.121393

Chicago

Naqvi, Ibtehaj, Nicholas Giroux, Lyra Olson, Sarah Ahn Morrison, Telmo Llanga, Tolu O Akinade, Yuefei Zhu, et al. 2022. “DAMPs/PAMPs Induce Monocytic TLR Activation and Tolerance in COVID-19 Patients; Nucleic Acid Binding Scavengers Can Counteract Such TLR Agonists.” Biomaterials 283 (April): 121393. doi:10.1016/j.biomaterials.2022.121393.